Neoadjuvant immunotherapy with chitosan and interleukin-12 to control breast cancer metastasis

Metastasis accounts for approximately 90% of breast cancer-related deaths. Therefore, novel approaches which prevent or control breast cancer metastases are of significant clinical interest. Interleukin-12 (IL-12)-based immunotherapies have shown promise in controlling metastatic disease, yet modest...

Descripción completa

Detalles Bibliográficos
Autores principales: Vo, Jimmy LN, Yang, Lirong, Kurtz, Samantha L, Smith, Sean G, Koppolu, Bhanu prasanth, Ravindranathan, Sruthi, Zaharoff, David A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352958/
https://www.ncbi.nlm.nih.gov/pubmed/25964864
http://dx.doi.org/10.4161/21624011.2014.968001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352958/
https://www.ncbi.nlm.nih.gov/pubmed/25964864
http://dx.doi.org/10.4161/21624011.2014.968001

Ejemplares similares